Evidence map›Paper›PMID 26647360›Full record

ArticleDepression and anxiety2015

HPA AXIS RELATED GENES AND RESPONSE TO PSYCHOLOGICAL THERAPIES: GENETICS AND EPIGENETICS.

Susanna Roberts, Robert Keers, Kathryn J Lester, Jonathan R I Coleman, Gerome Breen, Kristian Arendt, Judith Blatter-Meunier, Peter Cooper, Cathy Creswell, Krister Fjermestad and 18 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Depression and anxiety, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
17.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 104 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Epigenetic markers of response to psychotherapy in obsessive-compulsive disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  5. Article
  6. Article
  7. The role of epigenetics in anxiety disorders.Molecular biology reports · 2023
    Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 14 institutions in 9 countries.

Susanna RobertsMRC Social, Genetic and Developmental Psychiatry (SGDP) Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Robert KeersMRC Social, Genetic and Developmental Psychiatry (SGDP) Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Kathryn J LesterMRC Social, Genetic and Developmental Psychiatry (SGDP) Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Jonathan R I ColemanMRC Social, Genetic and Developmental Psychiatry (SGDP) Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Gerome BreenMRC Social, Genetic and Developmental Psychiatry (SGDP) Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Kristian ArendtDepartment of Psychology and Behavioural Sciences, Aarhus University, Aarhus, Denmark.
Judith Blatter-MeunierDepartment of Psychology, University of Basel, Basel, Switzerland.
Peter CooperSchool of Psychology and Clinical Language Sciences, University of Reading, United Kingdom.
Cathy CreswellSchool of Psychology and Clinical Language Sciences, University of Reading, United Kingdom.
Krister FjermestadAnxiety Disorders Research Network, Haukeland University Hospital, Bergen, Norway.
Odd E HavikAnxiety Disorders Research Network, Haukeland University Hospital, Bergen, Norway.
Chantal HerrenDepartment of Forensic Psychiatry, University of Basel Psychiatric Clinics, Basel, Switzerland.
Sanne M HogendoornDepartment of Child and Adolescent Psychiatry/De Bascule, Academic Medical Centre, Amsterdam, The Netherlands.
Jennifer L HudsonCentre for Emotional Health, Department of Psychology, Macquarie University, Sydney, Australia.
Karen KrauseDepartment of Psychology, Ruhr-Universität Bochum, Bochum, Germany.
Heidi J LynehamCentre for Emotional Health, Department of Psychology, Macquarie University, Sydney, Australia.
Talia MorrisCentre for Emotional Health, Department of Psychology, Macquarie University, Sydney, Australia.
Maaike NautaDepartment of Clinical Psychology and Experimental Psychopathology, University of Groningen, The Netherlands.
Ronald M RapeeCentre for Emotional Health, Department of Psychology, Macquarie University, Sydney, Australia.
Yasmin ReyChild Anxiety and Phobia Program, Department of Psychology, Florida International University, Miami, USA.
Silvia SchneiderDepartment of Psychology, Ruhr-Universität Bochum, Bochum, Germany.
Sophie C SchneiderCentre for Emotional Health, Department of Psychology, Macquarie University, Sydney, Australia.
Wendy K SilvermanChild Study Center, Yale University School of Medicine, New Haven, Connecticut, USA.
Mikael ThastumDepartment of Psychology and Behavioural Sciences, Aarhus University, Aarhus, Denmark.
Kerstin ThirlwallSchool of Psychology and Clinical Language Sciences, University of Reading, United Kingdom.
Polly WaiteSchool of Psychology and Clinical Language Sciences, University of Reading, United Kingdom.
Thalia C EleyMRC Social, Genetic and Developmental Psychiatry (SGDP) Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Chloe C Y WongMRC Social, Genetic and Developmental Psychiatry (SGDP) Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
King's College London · GBMacquarie University · AUUniversity of Reading · GBAarhus University · DKHaukeland University Hospital · NODe Bascule · NLFlorida International University · USRuhr University Bochum · DEStellenbosch University · ZAUniversitäre Psychiatrische Kliniken Basel · CHUniversity of Basel · CHUniversity of Groningen · NLUniversity of Sussex · GBYale University · US

Funding

Parent Mediation of Child Anxiety CBT OutcomeR01MH079943 · NIMH · FLORIDA INTERNATIONAL UNIVERSITY · PI PETTIT, JEREMY W · 2008 to 2012
$3.0M
Department of Health PB-PG-0107-12042Department of Health PB-PG-0110-21190Department of Health RP_2014-04-018Medical Research Council G0601020Medical Research Council G0601874Medical Research Council G0802326Medical Research Council G0901874Medical Research Council G0901874/1Medical Research Council G1002011Medical Research Council MR/J011762/1Medical Research Council MR/K021281/1NIMH NIH HHS R01 MH079943
6 · The paper itself

Abstract

backgroundHypothalamic-pituitary-adrenal (HPA) axis functioning has been implicated in the development of stress-related psychiatric diagnoses and response to adverse life experiences. This study aimed to investigate the association between genetic and epigenetics in HPA axis and response to cognitive behavior therapy (CBT).

methodsChildren with anxiety disorders were recruited into the Genes for Treatment project (GxT, N = 1,152). Polymorphisms of FKBP5 and GR were analyzed for association with response to CBT. Percentage DNA methylation at the FKBP5 and GR promoter regions was measured before and after CBT in a subset (n = 98). Linear mixed effect models were used to investigate the relationship between genotype, DNA methylation, and change in primary anxiety disorder severity (treatment response).

resultsTreatment response was not associated with FKBP5 and GR polymorphisms, or pretreatment percentage DNA methylation. However, change in FKBP5 DNA methylation was nominally significantly associated with treatment response. Participants who demonstrated the greatest reduction in severity decreased in percentage DNA methylation during treatment, whereas those with little/no reduction in severity increased in percentage DNA methylation. This effect was driven by those with one or more FKBP5 risk alleles, with no association seen in those with no FKBP5 risk alleles. No significant association was found between GR methylation and response.

conclusionsAllele-specific change in FKBP5 methylation was associated with treatment response. This is the largest study to date investigating the role of HPA axis related genes in response to a psychological therapy. Furthermore, this is the first study to demonstrate that DNA methylation changes may be associated with response to psychological therapies in a genotype-dependent manner.

Indexed as

Cognitive Behavioral TherapyAdolescentAllelesAnxiety DisordersChildChild, PreschoolDNA MethylationEpigenesis, GeneticEpigenomicsFemaleHumansHypothalamo-Hypophyseal SystemMalePituitary-Adrenal SystemPolymorphism, Single NucleotideReceptors, GlucocorticoidNR3C1 protein, humanReceptors, GlucocorticoidTacrolimus Binding Protein 5Tacrolimus Binding Proteinsanxietybiological markerschild/adolescentcognitive behavior therapyDNA methylationFKBP5geneticsglucocorticoid receptorHPA axistherapygeneticstreatment

Identifiers

PMID26647360
PMCPMC4982063
OpenAlexW1913150253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.